Wang; Xilu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Xilu.The latest application filed is for "macrocyclic mcl-1 inhibitors and methods of use".

Company Profile

18.59.99

Wang; Xilu - Libertyville IL
Wang; Xilu - Grayslake IL
Wang; Xilu - Oakwood IL
Wang; Xilu - Skokie IL
Wang; Xilu - Graylake IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20220259226 - Braje; Wilfried ; et al.	2022-08-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20210403467 - Tao; Zhi-Fu ; et al.	2021-12-30
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20210346369 - WANG; Le ; et al.	2021-11-11
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20210292339 - BRAJE; Wilfried ; et al.	2021-09-23
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20210228565 - Wang; Le ; et al.	2021-07-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20210221789 - Bruncko; Milan ; et al.	2021-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200345717 - WANG; Le ; et al.	2020-11-05
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200331907 - Tao; Zhi-Fu ; et al.	2020-10-22
Macrocyclic MCL-1 Inhibitors and Methods of Use App 20200325153 - Judd; Andrew S. ; et al.	2020-10-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200277291 - Tao; Zhi-Fu ; et al.	2020-09-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200253954 - Kind Code	2020-08-13
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20200255451 - Kind Code	2020-08-13
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20200246460 - Kind Code	2020-08-06
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors App 20200246323 - Kind Code	2020-08-06
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20200239553 - Ackler; Scott L. ; et al.	2020-07-30
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20200239494 - BRAJE; Wilfried ; et al.	2020-07-30
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200231566 - Bruncko; Milan ; et al.	2020-07-23
Macrocyclic MCL-1 inhibitors and methods of use Grant 10,676,485 - Judd , et al.	2020-06-09
Macrocyclic MCL-1 Inhibitors and Methods of Use App 20200010480 - Brady; Patrick B. ; et al.	2020-01-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20190315737 - Tao; Zhi-Fu ; et al.	2019-10-17
Macrocyclic MCL-1 inhibitors and methods of use App 20190144465 - Judd; Andrew S. ; et al.	2019-05-16
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20190142941 - Ackler; Scott L. ; et al.	2019-05-16
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20190119247 - Bruncko; Milan ; et al.	2019-04-25
Macrocyclic MCL-1 inhibitors and methods of use App 20190055264 - Brady; Patrick B. ; et al.	2019-02-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180354952 - Tao; Zhi-Fu ; et al.	2018-12-13
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 10,081,628 - Tao , et al. September 25, 2	2018-09-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ; et al.	2018-09-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180221363 - WANG; Le ; et al.	2018-08-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180140595 - Wang; Le ; et al.	2018-05-24
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases Grant 9,877,958 - Wang , et al. January 30, 2	2018-01-30
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,844,547 - Wang , et al. December 19, 2	2017-12-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20170296531 - Wang; Le ; et al.	2017-10-19
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors App 20170182179 - Ackler; Scott L. ; et al.	2017-06-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20170158666 - Bruncko; Milan ; et al.	2017-06-08
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20170096424 - Tao; Zhi-Fu ; et al.	2017-04-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20170008891 - Tao; Zhi-Fu ; et al.	2017-01-12
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20160339117 - Ackler; Scott L. ; et al.	2016-11-24
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,403,822 - Tao , et al. August 2, 2	2016-08-02
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160206611 - Wang; Le ; et al.	2016-07-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160158218 - Wang; Le ; et al.	2016-06-09
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20160158377 - Ackler; Scott L. ; et al.	2016-06-09
7-substituted indole Mcl-1 inhibitors Grant 9,359,296 - Wang , et al. June 7, 2	2016-06-07
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,303,025 - Bruncko , et al. April 5, 2	2016-04-05
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,266,877 - Wang , et al. February 23, 2	2016-02-23
Apoptosis-inducing Agent For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160002187 - Kunzer; Aaron R. ; et al.	2016-01-07
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,227,963 - Wang , et al. January 5, 2	2016-01-05
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150329541 - Bruncko; Milan ; et al.	2015-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,174,982 - Bruncko , et al. November 3, 2	2015-11-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150299197 - Tao; Zhi-Fu ; et al.	2015-10-22
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,156,856 - Kunzer , et al. October 13, 2	2015-10-13
7-substituted Indole Mcl-1 Inhibitors App 20150284328 - Wang; Xilu ; et al.	2015-10-08
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150246914 - Tao; Zhi-Fu ; et al.	2015-09-03
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,073,855 - Doherty , et al. July 7, 2	2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ; et al.	2015-07-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150152097 - Wang; Le ; et al.	2015-06-04
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,045,420 - Doherty , et al. June 2, 2	2015-06-02
Apoptosis promoters Grant 9,045,444 - Ding , et al. June 2, 2	2015-06-02
7-substituted indole Mcl-1 inhibitors Grant 9,035,047 - Wang , et al. May 19, 2	2015-05-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,029,404 - Doherty , et al. May 12, 2	2015-05-12
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,006,247 - Tao , et al. April 14, 2	2015-04-14
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150072978 - Wang; Le ; et al.	2015-03-12
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,940,737 - Wang , et al. January 27, 2	2015-01-27
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,889,675 - Wang , et al. November 18, 2	2014-11-18
1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives Grant 8,853,209 - Song , et al. October 7, 2	2014-10-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140275082 - Tao; Zhi-Fu ; et al.	2014-09-18
Apoptosis Promoters App 20140187531 - Bruncko; Milan ; et al.	2014-07-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140113910 - Bruncko; Milan ; et al.	2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140094471 - Bruncko; Milan ; et al.	2014-04-03
Apoptosis promoters Grant 8,686,136 - Bruncko , et al. April 1, 2	2014-04-01
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ; et al.	2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
7-substituted Indole Mcl-1 Inhibitors App 20140051683 - WANG; Xilu ; et al.	2014-02-20
Apoptosis promoters Grant 8,614,318 - Bruncko , et al. December 24, 2	2013-12-24
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2	2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ; et al.	2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2	2013-10-22
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,557,983 - Doherty , et al. October 15, 2	2013-10-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130267514 - Bruncko; Milan ; et al.	2013-10-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130267534 - Bruncko; Milan ; et al.	2013-10-10
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,546,399 - Bruncko , et al. October 1, 2	2013-10-01
Apoptosis Promoters App 20130190488 - Bruncko; Milan ; et al.	2013-07-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130184278 - KUNZER; Aaron R. ; et al.	2013-07-18
7-substituted indole MCL-1 inhibitors Grant 8,445,679 - Wang , et al. May 21, 2	2013-05-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130096121 - Wang; Le ; et al.	2013-04-18
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130096120 - WANG; LE ; et al.	2013-04-18
Apoptosis promoters Grant 8,354,404 - Bruncko , et al. January 15, 2	2013-01-15
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,338,466 - Kunzer , et al. December 25, 2	2012-12-25
Heterocyclic compounds and methods of use Grant 8,232,273 - Baell , et al. July 31, 2	2012-07-31
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120190688 - Bruncko; Milan ; et al.	2012-07-26
Apoptosis promoters Grant 8,173,811 - Bruncko , et al. May 8, 2	2012-05-08
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120028925 - Tao; Zhi-Fu ; et al.	2012-02-02
Apoptosis promoters Grant 8,084,607 - Bruncko , et al. December 27, 2	2011-12-27
7-nonsubstituted Indole Mcl-1 Inhibitors App 20110263599 - Song; Xiaohong ; et al.	2011-10-27
Apoptosis Promoters App 20110256129 - Bruncko; Milan ; et al.	2011-10-20
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives Grant 7,981,888 - Song , et al. July 19, 2	2011-07-19
Apoptosis promoters Grant 7,973,161 - Bruncko , et al. July 5, 2	2011-07-05
Apoptosis Promoters App 20110144112 - Bruncko; Milan ; et al.	2011-06-16
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20110124628 - Bruncko; Milan ; et al.	2011-05-26
Apoptosis promoters Grant 7,906,505 - Bruncko , et al. March 15, 2	2011-03-15
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100305122 - Bruncko; Milan ; et al.	2010-12-02
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ; et al.	2010-11-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ; et al.	2010-11-25
Apoptosis Promoters App 20100249133 - Bruncko; Milan ; et al.	2010-09-30
Apoptosis promoters App 20100240715 - Bruncko; Milan ; et al.	2010-09-23
Heterocyclic Compounds And Methods Of Use App 20100210622 - Baell; Jonathan Bayldon ; et al.	2010-08-19
Macrocyclic inhibitors of BCL proteins Grant 7,777,076 - Elmore , et al. August 17, 2	2010-08-17
Apoptosis promoters Grant 7,767,684 - Bruncko , et al. August 3, 2	2010-08-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100184766 - Kunzer; Aaron R. ; et al.	2010-07-22
N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2	2010-07-13
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ; et al.	2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ; et al.	2010-06-17
Apoptosis promoters Grant 7,709,467 - Bruncko , et al. May 4, 2	2010-05-04
Apoptosis Promoters App 20100022773 - Bruncko; Milan ; et al.	2010-01-28
Apoptosis promoters Grant 7,642,260 - Bruncko , et al. January 5, 2	2010-01-05
N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ; et al.	2009-05-28
7-nonsubstituted Indole Mcl-1 Inhibitors App 20090124616 - Song; Xiaohong ; et al.	2009-05-14
N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2	2009-03-17
7-substituted Indole Mcl-1 Inhibitors App 20090054402 - Wang; Xilu ; et al.	2009-02-26
Apoptosis Promoters App 20080287419 - Bruncko; Milan ; et al.	2008-11-20
N-sulfonylurea apoptosis promoters Grant 7,449,485 - Elmore , et al. November 11, 2	2008-11-11
Apoptosis Promoters App 20080194691 - Elmore; Steven W. ; et al.	2008-08-14
Apoptosis promoters Grant 7,390,799 - Bruncko , et al. June 24, 2	2008-06-24
N-sulfonylurea Apoptosis Promoters App 20080146572 - Elmore; Steven W. ; et al.	2008-06-19
N-sulfonylurea apoptosis promoters Grant 7,358,251 - Elmore , et al. April 15, 2	2008-04-15
Farnesyltransferase inhibitors Grant 7,323,570 - Claiborne , et al. January 29, 2	2008-01-29
Farnesyltransferase inhibitors Grant 7,211,595 - Claiborne , et al. May 1, 2	2007-05-01
Apoptosis promoters App 20070072860 - Bruncko; Milan ; et al.	2007-03-29
Apoptosis promoters App 20070027135 - Bruncko; Milan ; et al.	2007-02-01
Apoptosis promoters App 20070015787 - Bruncko; Milan ; et al.	2007-01-18
Farnesyltransferase Inhibitors App 20060264476 - Claiborne; Akiyo K. ; et al.	2006-11-23
Apoptosis promoters App 20060258657 - Bruncko; Milan ; et al.	2006-11-16
Apoptosis promoters App 20060128706 - Bruncko; Milan ; et al.	2006-06-15
N-sulfonylurea apoptosis promoters Grant 7,030,115 - Elmore , et al. April 18, 2	2006-04-18
N-sulfonylurea apoptosis promoters App 20060074085 - Elmore; Steven W. ; et al.	2006-04-06
N-acylsulfonamide apoptosis promoters App 20050159427 - Bruncko, Milan ; et al.	2005-07-21
N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ; et al.	2004-09-30
N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2	2004-04-13
N-sulfonylurea apoptosis promoters App 20030236247 - Elmore, Steven W. ; et al.	2003-12-25
Farnesyltransferase inhibitors App 20030087940 - Claiborne, Akiyo K. ; et al.	2003-05-08
Farnesyltransferase inhibitors App 20020115640 - Claiborne, Akiyo K. ; et al.	2002-08-22
N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ; et al.	2002-07-04
N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ; et al.	2002-05-09
Substituted phenyl farnesyltransferase inhibitors App 20020019527 - Wang, Wei-Bo ; et al.	2002-02-14

Company Registrations

NCAGE Code	64D80	WANG XILU
CAGE Code	64D80	WANG XILU

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.